We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$60.8B
1-Year Est. Return
42.06%
This Fund
S&P 500
This Quarter
Est. Return
+9.93%
1 Year Est. Return
+42.06%
3 Year Est. Return
+131.09%
5 Year Est. Return
+176.11%
10 Year Est. Return
–
AUM
$49.3B
AUM Growth
+$3.1B
(+6.7%)
Cap. Flow
-$516M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
27.74%
Holding
1,796
New
24
Increased
581
Reduced
361
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$78.5M |
| 2 |
NVIDIA
NVDA
|
+$75.6M |
| 3 |
Eli Lilly
LLY
|
+$70.2M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$58.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$55.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$107M |
| 2 |
Pfizer
PFE
|
+$70M |
| 3 |
Johnson & Johnson
JNJ
|
+$68M |
| 4 |
Danaher
DHR
|
+$56.4M |
| 5 |
Walmart Inc
WMT
|
+$54.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.47% |
| 2 | Healthcare | 17.5% |
| 3 | Financials | 11.6% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
CBRE Group
CBRE
$42.8B
| $26.9M | 0.05% |
333,729
-136,692
| -29% | -$10.2M |
|
252
IDEX
IEX
$16.5B
| $26.8M | 0.05% |
124,729
+32,488
| +35% | +$6.83M |
|
253
RB Global
RBA
$15.5B
| $26.5M | 0.05% |
441,821
+21,904
| +5% | +$1.24M |
|
254
Casella Waste Systems
CWST
$5.95B
| $26.5M | 0.05% |
292,693
+277,053
| +1,771% | +$24.7M |
|
255
Constellation Energy
CEG
$106B
| $26.2M | 0.05% |
286,576
-10,366
| -3% | -$859K |
|
256
DoorDash
DASH
$91.7B
| $26.1M | 0.05% |
341,492
+11,631
| +4% | +$772K |
|
257
Royalty Pharma
RPRX
$28.5B
| $25.9M | 0.05% |
842,540
-28,274
| -3% | -$958K |
|
258
Equinix
EQIX
$102B
| $25.3M | 0.05% |
32,331
+9,654
| +43% | +$7.07M |
|
259
Phathom Pharmaceuticals
PHAT
$769M
| $25.2M | 0.05% |
1,757,127
-4,064
| -0.2% | -$46.9K |
|
260
Snowflake
SNOW
$117B
| $25.1M | 0.05% |
142,768
+53,121
| +59% | +$8.64M |
|
261
Campbell Soup
CPB
$6.38B
| $25M | 0.05% |
547,019
+6,740
| +1% | +$348K |
|
262
PNC Financial Services
PNC
$98B
| $24.6M | 0.05% |
195,334
+110,842
| +131% | +$13.5M |
|
263
HealthEquity
HQY
$7.95B
| $24.6M | 0.05% |
388,904
+15,097
| +4% | +$875K |
|
264
STAAR Surgical
STAA
$1.18B
| $24.1M | 0.05% |
458,601
+12,084
| +3% | +$736K |
|
265
Dorman Products
DORM
$3.9B
| $24M | 0.05% |
304,428
+12,128
| +4% | +$1.02M |
|
266
3M
MMM
$86.9B
| $24M | 0.05% |
286,672
-93,042
| -25% | -$7.9M |
|
267
Diamondback Energy
FANG
$55.8B
| $23.7M | 0.05% |
180,555
-12,960
| -7% | -$1.73M |
|
268
Ingersoll Rand
IR
$29.6B
| $23.7M | 0.05% |
362,453
+1,270
| +0.4% | +$75.1K |
|
|
PPL
269
PPL Corp
PPL
$26.4B
| $23.5M | 0.05% |
888,371
+39,029
| +5% | +$1.08M |
|
270
Progressive
PGR
$127B
| $23.4M | 0.05% |
176,499
+59,094
| +50% | +$7.92M |
|
271
Tyson Foods
TSN
$18.1B
| $23.4M | 0.05% |
457,539
-242,039
| -35% | -$13.2M |
|
272
Cadence Design Systems
CDNS
$80.6B
| $23.3M | 0.05% |
99,249
+16,794
| +20% | +$3.65M |
|
273
Fidelity National Information Services
FIS
$21.6B
| $23.2M | 0.05% |
424,209
+149,548
| +54% | +$8.23M |
|
274
Global Payments
GPN
$24.5B
| $23.1M | 0.05% |
234,186
+219,420
| +1,486% | +$22.6M |
|
275
Edwards Lifesciences
EW
$51.8B
| $22.8M | 0.05% |
241,464
+10,610
| +5% | +$922K |
|
Similar funds
Ensign Peak Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Ensign Peak Advisors held 1,796 positions worth $49.3B, up 6.7% from $46.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 3.3%. Ensign Peak Advisors opened 24 new positions and exited 35, leaving the 1,796-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q2 2023 buy was First Horizon: 875,834 shares worth $9.87M.
- Ensign Peak Advisors added most to Microsoft in Q2 2023, an estimated $78.5M increase.
- Ensign Peak Advisors's biggest Q2 2023 reduction was AbbVie, cutting an estimated $107M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $45M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $49.3B portfolio in Q2 2023.
- Ensign Peak Advisors opened 24 new positions and closed 35 in Q2 2023.
- Ensign Peak Advisors's portfolio value rose 6.7% quarter-over-quarter to $49.3B.
Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.